About Contact Us Careers

Aortic Stenosis Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3125
Published Date: Sep 02, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Aortic Stenosis Treatment Landscape

Edwards Lifesciences Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
JenaValve Technology, Inc.
Neovasc Inc.
HighLife SAS
Abbott Laboratories
B. Braun Melsungen AG
CryoLife Inc.
Boston Scientific Corporation
Medtronic PLC
Siemens Healthcare GmbH

Browse Key Market Insights with Data Illustration:

Aortic Stenosis Treatment Market Size & Share, Growth Analysis 2036

In the News

· May 18, 2021: Edwards Lifesciences Corporation announced the positive results of SAPIEN 3TAVR for patients with bicuspid aortic stenosis.

· December 15, 2021: Neovasc Inc. announced the completion of its first three Neovasc Reducer implants in France.

Author Credits: Radhika Pawar

Report ID: 3125
Published Date: Sep 02, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of aortic stenosis treatment is estimated at USD 7.44 billion.

Aortic Stenosis Treatment Market size was valued at USD 6.91 billion in 2023 and is likely to reach USD 22.48 billion by 2036, expanding at around 9.5% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of aortic stenosis, among other valvular heart diseases, will boost the market growth.

Asia Pacific is likely to hold largest revenue share by 2036, on the back of high cases of valve diseases in the region.

The major players in the market are Edwards Lifesciences Corporation, Neovasc Inc., HighLife SAS, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, CryoLife Inc., Siemens Healthcare GmbH, and others.

Inquiry Before Buying Request Free Sample